Collectively, FBXW7 acts as a tumor suppressor in ESCC by promoting the degradation of both SPT6 and ΔNp63, and the SPT6-ΔNp63 axis may serve as a therapeutic target for ESCC. This evidence concerns the gene SUPT6H and neoplasm.